# FDA Inspection 1254819 - Acrotech Biopharma Inc. - November 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/f0ec4968-f49d-4d2a-a936-12f0a2711b4b
Source feed: FDA_Inspections

> FDA Inspection 1254819 for Acrotech Biopharma Inc. on November 18, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254819
- Company Name: Acrotech Biopharma Inc.
- Inspection Date: 2024-11-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1254819 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/62439d93-33a4-40ca-9c3c-264a28011ab8)
- [FDA Inspection 1195306 - 2023-01-19](https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/d8adac73-ddbc-4993-a60b-4ef35c107440)

Company: https://www.keypedia.com/companies/acrotech-biopharma-inc/3311a997-8df4-4dc6-9137-27367ba84188

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248